MedicaTour drives Russian medical tourism growth

MedicaTour has specialised in medical tourism for more than 13 years. It works with more than 500 clinics around the world, sending them patients from Russia and the CIS. The company also promotes the export of medical services from Russia and helps foreign clinics market their services within Russia and the CIS. Tatiana Sokolov began by outlining the rm’s day-to-day operations.

Regarding day-to-day work, we have two departments: one is engaged in all procedures related to patients (processing requests, searching institutions, co-ordinating actions between patients and clinics etc), the another in the development and implementation of marketing and PR strategies for our partner clinics.

How is medical tourism evolving/ growing?
In the last three years, we have seen a decrease in the number of patients from Russia travelling abroad for treatment. This is due to the economic crisis, the devaluation of the rouble and sanctions. But at the same time the export of medical services has begun to actively develop and more patients are coming to us from around the world.


What do you see as being the key trends in medical tourism from your clients’ point of view
We focus on unique treatment methods for our patients, such as immunotherapy of cancer with dendritic cells, treatment of type 2 diabetes by bariatric surgery,

treatment of optic nerve atrophy with a soft laser, treatment of diabetic foot with the help of the drug Laxavitar, which was invented in Russia.

How important is ITB as a platform for contacts and new ideas for you, and why is it important to be a member of the Buyers’ Circle?
This year I am taking part for the first time, but I have heard a lot about it from my colleagues. I think that for all players in the medical tourism market it is very useful to communicate with colleagues, meet new potential partners, exchange ideas and experience and to know how colleagues from other countries work.

Photo: Tatiana Sokolov, CEO MedicaTour